[Federal Register Volume 74, Number 63 (Friday, April 3, 2009)]
[Notices]
[Pages 15296-15297]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-7704]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of a Conference Call of a Working Group of the NIH Blue
Ribbon Panel
The purpose of this notice is to inform the public about a
conference call of the NIH Blue Ribbon Panel to Advise on the Risk
Assessment of the National Emerging Infectious Diseases Laboratories at
Boston University Medical Center. This meeting is the first in a series
of public meetings to review and discuss the ongoing supplementary risk
assessment study.
The conference call will be held on Tuesday, April 7, 2009 from
approximately 11 a.m. to 1 p.m. The toll-free number to participate in
the call is 1-800-779-2616. Indicate to the conference operator that
your participant passcode is ``NIH.''
The panel will review earlier National Research Council (NRC)
recommendations regarding a supplementary risk assessment study, Blue
Ribbon Panel recommendations regarding various aspects of the risk
assessment study, and a new Statement of Task for the NRC.
Public comment will begin at approximately 12:45 p.m. In the event
that time does not allow for all those interested to present oral
comments, anyone may file written comments by sending them to the
address below. Comments should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the commenter.
A draft agenda and slides for the meeting may be obtained by
connecting to http://nihblueribbonpanel-bumc-
[[Page 15297]]
neidl.od.nih.gov/. For additional information concerning this meeting,
contact Ms. Laurie Lewallen, Advisory Committee Coordinator, Office of
Biotechnology Activities, Office of Science Policy, Office of the
Director, National Institutes of Health, 6705 Rockledge Drive, Room
750, Bethesda, MD 20892-7985; telephone 301-496-9838; e-mail
[email protected].
Dated: March 31, 2009.
Amy P. Patterson,
Acting Director, Office of Science Policy, National Institutes of
Health.
[FR Doc. E9-7704 Filed 4-2-09; 8:45 am]
BILLING CODE 4140-01-P